Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients

NCT04137185 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Differentiated Thyroid Cancer

Interventions

DRUG: Recombinant Human Thyroid Stimulating Hormone for Injection

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd